| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | SAGE THERAPEUTICS | 8,773,073 | 640,434,000 | 66.66% | ||
| 2 | BLUEPRINT MEDICINES CORP COM | 7,393,059 | 195,842,000 | 20.38% | ||
| 3 | ZAFGEN INC COM | 3,202,045 | 110,887,000 | 11.54% | ||
| 4 | ELEVEN BIOTHERAPEUTICS INC | 4,841,591 | 13,653,000 | 1.42% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001012975-15-000564, filed 2015.07.30).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
